Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen-specific therapies in multiple sclerosis.

Mireia Sospedra1, Roland Martin

  • 1Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

International Reviews of Immunology
|December 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic immune tolerance for central nervous system autoimmune diseases - Prospects, challenges and pitfalls.

Seminars in immunology·2026
Same author

Distinct Clinico-pathogenic Subgroups in Pediatric Lyme Neuroborreliosis.

Open forum infectious diseases·2026
Same author

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis.

Cell·2026
Same author

EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation.

Cell·2026
Same author

Protocol for the characterization of autoproliferating B and T cells from persons with multiple sclerosis.

STAR protocols·2025
Same author

HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry.

Journal for immunotherapy of cancer·2025
Same journal

Regulatory T cells in the tumor microenvironment: Mechanisms and clinical implications.

International reviews of immunology·2026
Same journal

Leptin in metabolic-immune crosstalk: Mechanisms of T cell regulation and implications for autoimmune disease therapy.

International reviews of immunology·2026
Same journal

Metabolic alterations in the tumor microenvironment influence the anti-tumor immune function of CD8<sup>+</sup> T cells via epigenetic modifications.

International reviews of immunology·2026
Same journal

Macrophage markers and gene signature profiling reveals mesenchymal stem cells mediated immune modulation in Plasmodium berghei ANKA infection.

International reviews of immunology·2026
Same journal

Natural antigen landscape shaping intestinal Treg cells: Self, diet, and microbiota.

International reviews of immunology·2026
Same journal

Upregulation of ADAM10 reinforces CD8<sup>+</sup> T cells toward exhaustion in the TME.

International reviews of immunology·2026
See all related articles

New antigen-specific immunotherapies aim to restore tolerance for autoimmune diseases like multiple sclerosis (MS). These targeted approaches offer hope for effective treatment with fewer side effects than previous methods.

Area of Science:

  • Immunology
  • Neuroimmunology
  • Translational Medicine

Background:

  • Many novel therapies for autoimmune diseases, including multiple sclerosis (MS), show promise in preclinical studies but frequently fail in clinical trials due to lack of efficacy or unacceptable adverse events.
  • Past attempts at antigen-specific immunomodulation have yielded disappointing results, prompting a re-evaluation of strategies.

Purpose of the Study:

  • To review current antigen-specific immunotherapy approaches for multiple sclerosis (MS).
  • To explore strategies focused on reestablishing immune tolerance to autoantigens in MS.

Main Methods:

  • Review of existing literature on antigen-specific immunotherapies for MS.
  • Analysis of approaches targeting T cell-mediated and/or antibody-mediated immune responses.

Related Experiment Videos

Main Results:

  • Despite past challenges, renewed interest exists in antigen-specific immunotherapies for MS.
  • These therapies aim to correct pathological immune responses against autoantigens with high specificity.

Conclusions:

  • Antigen-specific immunotherapies hold significant potential for treating MS by restoring immune tolerance.
  • These approaches may offer a more effective and safer therapeutic strategy compared to broadly immunosuppressive treatments.